Portfolio company
Lucid Genomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genomenon
This company develops genomic search engines and data platforms for pharmaceutical companies and clinical laboratories to assist in disease diagnosis and drug development.
LUCAI
LUCAI provides artificial intelligence solutions for molecular design and clinical diagnostics to pharmaceutical and biotechnology companies.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
Nygen
This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
intoDNA
This company develops an AI-powered platform for detecting and quantifying DNA damage in cells to support pharmaceutical companies with drug development and diagnostics.
Qnomx
Qnomx develops an AI platform for molecular diagnostics laboratories to interpret genomic sequencing data and generate clinical reports for precision oncology.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
